Analytics & Research
Researchers at Houston Methodist have identified a promising new therapeutic target that could help overcome treatment resistance in advanced breast cancer patients.
The Department of Health and Human Services announced a new clinical trials program through the Advanced Research Projects Agency for Health, or ARPA-H, that is designed to evaluate drugs and biologics faster, at lower cost and with fewer participants.
Children’s Hospital Colorado helped the National Alliance of Sickle Cell Centers develop new national standards to improve how developmental and cognitive challenges are identified and managed in people with sickle cell disease (SCD).
Houston Methodist is transforming their inpatient care through remote monitoring technology that gives clinicians a continuous view of a patient’s condition instead of traditional vital-sign checks every four hours.
An Iowa cancer patient is helping shape the future of treatment by turning a life-altering diagnosis into a mission to advance research and support other patients.
When it comes to liver cancer, you may already know classic risk factors like cirrhosis or chronic hepatitis B and C viruses. But a Seattle-based epidemiologist at Fred Hutchinson Cancer Center is investigating a lesser-known potential contributor that may not be on your radar: solar jet lag.
Enhanced infection prevention measures in neonatal intensive care units have been shown to significantly reduce the spread of hospital‑acquired viral infections among highly vulnerable infants, according to a study led by Oregon Health & Science University.
A JAMA study published March 18 found that women who experience premature menopause have a 40% higher lifetime risk of coronary heart disease.
Mayo Clinic launched Platform_Insights, a new data and analytics offering designed to give health systems around the world access to its clinical expertise, large-scale datasets and advanced AI capabilities.
The Department of Health and Human Services Aug. 7 announced it will no longer fund mRNA vaccine development under the Biomedical Advanced Research and Development Authority.